Skip to content

The Observational Cohort Study on Changes in Complement Levels in Trauma Patients and Their Correlation with Disease Severity and Prognosis

The Observational Cohort Study on Changes in Complement Levels in Trauma Patients and Their Correlation with Disease Severity and Prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097309
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Interventions

Trauma Group:Trauma caused by accidental injury
Control Group:Recruited healthy volunteers

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age Limitations: Participants must be over 18 years old to ensure that the study subjects have a mature immune system and stable physiological state. 2.Trauma Type: Participants must have sustained trauma due to accidental injuries, including traffic accidents, falls, sports injuries, etc., to ensure homogeneity within the study population. 3.Treatment Requirement: Participants must require hospitalization due to the severity of their trauma, ensuring that the study focuses on trauma patients who need medical intervention. 4.Admission Time: Participants must be admitted within 24 hours after trauma to minimize the impact of delayed post-traumatic time on complement level measurements.

Exclusion criteria

Exclusion criteria: 1.Severely Impaired Immune Function: Exclude patients with hematological diseases, HIV, tumors, or other conditions causing severe immune dysfunction, as these conditions may affect complement system activity. 2.Medication Effects: Exclude patients who have been taking medications that impact immune function, such as corticosteroids or immunosuppressants, to avoid interference with complement levels. 3.Special Physiological States: Exclude lactating or pregnant women, as hormonal changes and the presence of the fetus may affect the complement system. 4.Treatment Willingness: Exclude patients who refuse treatment to ensure that all participants receive standard trauma care and necessary medical interventions. 5.Comorbidity Restrictions: Exclude patients with severe cardiac, pulmonary, hepatic, or renal dysfunction, as these comorbidities may affect complement system activity and trauma prognosis. 6.Previous Surgery History: Exclude patients who have undergone major surgery within the past 6 months to reduce the potential impact of surgery on complement levels and trauma prognosis. 7.Infection Status: Exclude patients with active infections at the time of admission, as infections may activate the complement system and affect the interpretation of study results. 8.Drug Allergy History: Record any history of drug allergies (especially to drugs that may be used in the study) to avoid severe allergic reactions during the research. 9.Lifestyle Factors: Record smoking and drinking habits, as these factors may affect immune function and the trauma healing process. 10.Psychological Status: Assess the patient's mental health status and exclude individuals with severe psychological disorders or cognitive impairments, as these conditions may affect the patient’s cooperation and the accuracy of study results.

Design outcomes

Primary

MeasureTime frame
Complement C1q, Bb, MBL, C3b, C3a, C5a, sC5b-9, tissue factor, thrombin, and CD59;

Secondary

MeasureTime frame
IL-6,TNF-a;

Countries

China

Contacts

Public ContactShanshan Mei

Shenzhen People's Hospital

mayshem@163.com+86 136 5232 3337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026